Nektar Therapeutics (NKTR)
1.65
+0.08
(+5.10%)
USD |
NASDAQ |
May 06, 16:00
1.65
0.00 (0.00%)
After-Hours: 20:00
Nektar Therapeutics Gross Profit (TTM): 56.35M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 56.35M |
September 30, 2023 | 55.54M |
June 30, 2023 | 62.48M |
March 31, 2023 | 65.45M |
December 31, 2022 | 70.42M |
September 30, 2022 | 73.48M |
June 30, 2022 | 74.43M |
March 31, 2022 | 78.63M |
December 31, 2021 | 77.01M |
September 30, 2021 | 77.30M |
June 30, 2021 | 82.16M |
March 31, 2021 | 104.57M |
December 31, 2020 | 133.44M |
September 30, 2020 | 142.17M |
June 30, 2020 | 142.00M |
March 31, 2020 | 117.22M |
December 31, 2019 | 93.24M |
September 30, 2019 | 97.74M |
June 30, 2019 | 96.42M |
March 31, 2019 | 1.160B |
December 31, 2018 | 1.169B |
September 30, 2018 | 1.222B |
June 30, 2018 | 1.347B |
March 31, 2018 | 289.94M |
December 31, 2017 | 277.16M |
Date | Value |
---|---|
September 30, 2017 | 222.30M |
June 30, 2017 | 104.35M |
March 31, 2017 | 103.81M |
December 31, 2016 | 135.22M |
September 30, 2016 | 135.38M |
June 30, 2016 | 159.27M |
March 31, 2016 | 146.34M |
December 31, 2015 | 196.68M |
September 30, 2015 | 178.93M |
June 30, 2015 | 249.39M |
March 31, 2015 | 260.67M |
December 31, 2014 | 172.17M |
September 30, 2014 | 181.11M |
June 30, 2014 | 105.49M |
March 31, 2014 | 110.93M |
December 31, 2013 | 110.41M |
September 30, 2013 | 102.08M |
June 30, 2013 | 65.23M |
March 31, 2013 | 52.86M |
December 31, 2012 | 50.76M |
September 30, 2012 | 47.24M |
June 30, 2012 | 58.08M |
March 31, 2012 | 50.80M |
December 31, 2011 | 49.59M |
September 30, 2011 | 74.33M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
55.54M
Minimum
Sep 2023
142.17M
Maximum
Sep 2020
89.48M
Average
78.63M
Median
Mar 2022
Gross Profit (TTM) Benchmarks
Stereotaxis Inc | 14.86M |
Vanda Pharmaceuticals Inc | 177.84M |
Cara Therapeutics Inc | 14.79M |
Avid Bioservices Inc | 10.21M |
Rigel Pharmaceuticals Inc | 109.77M |